JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jimenez-Asensio, J.
Right arrow Articles by Garland, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jimenez-Asensio, J.
Right arrow Articles by Garland, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 45, 32287-32294, November 5, 1999


An Atypical Form of alpha B-crystallin Is Present in High Concentration in Some Human Cataractous Lenses
IDENTIFICATION AND CHARACTERIZATION OF ABERRANT N- AND C-TERMINAL PROCESSING*

Jose Jimenez-AsensioDagger , Christine M. ColvisDagger , Jeffrey A. Kowalak§, Yvonne Duglas-Tabor, Manuel B. Datiles, Maria Moroni, Umberto Mura, Ch. Mohan Raoparallel , Dorairajan Balasubramanian**, Alireza JanjaniDagger Dagger , and Donita Garland§§

From the NEI and the § NICHHD, National Institutes of Health, Bethesda, Maryland 20892, the  University of Pisa, 56100 Pisa, Italy, the parallel  Center for Cellular and Molecular Biology, 500 007 Hyderabad, India, and the ** L.V. Prasad Eye Institute, 500 034 Hyderabad, India

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Two unique polypeptides, 22.4 and 16.4 kDa, were prominent in some human cataracts. Both proteins were identified as modified forms of the small heat shock protein, alpha B-crystallin. The concentration of total alpha B-crystallin in most of these cataracts was significantly increased. The 22.4-kDa protein was subsequently designated as alpha Bg. Mass spectrometric analyses of tryptic and Asp-N digests showed alpha Bg is alpha B-crystallin minus the C-terminal lysine. alpha Bg constituted 10-90% of the total alpha B-crystallin in these cataracts and was preferentially phosphorylated over the typical form of alpha B-crystallin. Human alpha Bg and alpha B-crystallin were cloned and expressed in Escherichia coli. The differences in electrophoretic mobility and the large difference in native pI values suggest some structural differences exist. The chaperone-like activity of recombinant human alpha Bg was comparable to that of recombinant human alpha B-crystallin in preventing the aggregation of lactalbumin induced by dithiothreitol. The mechanism involved in generating alpha Bg is not known, but a premature termination of the alpha B-crystallin gene was ruled out by sequencing the polymerase chain reaction products of the last exon for the alpha B-crystallin gene from lenses containing alpha Bg. The 16.4-kDa protein was an N-terminally truncated fragment of alpha Bg. The high concentration of alpha B-crystallin in these cataracts is the first observation of this kind in human lenses.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The three major classes of mammalian crystallins, alpha -, beta -, and gamma -crystallins, constitute about 90% of the total protein in the eye lens and are considered to determine the refractive properties of the lens. Post-translational modification of the crystallins has been a major focus of the research in trying to elucidate causes for the loss of lens transparency or cataract development (1-4). alpha -Crystallins have received the most attention in this case. The two homologous subunits, alpha A- and alpha B-crystallin, make up about 30% of the proteins in young human lenses and in the outer cortex of the adult human lens. alpha B-crystallin is a normal constituent of most mammalian tissues but is present in the highest concentrations in lens (5, 6). In addition to the lens, alpha A-crystallin is found in spleen and thymus (7). alpha -Crystallins are present in fiber cell extracts as large heteroaggregates with apparent molecular masses reported from 300 to 1000 kDa (8, 9). In cataracts the sizes of the aggregates reportedly increase and these aggregates are thought to be responsible for the light scattering (2).

On the other hand, alpha -crystallins are members of the family of small heat shock proteins and are thought to provide protection against cellular stresses (10-12). Members of this family are structurally related via the alpha -crystallin domain, they form large aggregates, are phospho-proteins, and have chaperone-like activity (12-19). alpha - Crystallins prevent the aggregation of proteins induced by heat, oxidation, or chemicals. In cultured cells, expression of alpha B-crystallin is induced by heat shock, oxidative stress, osmotic stress, arsenite, phorbol 12-myristate 13-acetate, and hormones such as estrogen and dexamethasone (20-23). Thus, the role of alpha B-crystallin in many systems is considered to be that of a stress protein. In the lens, however, it is not known whether the primary function of alpha B-crystallin is that of a stress protein and related to its chaperone-like function or if its major role is structural. It is possible its role in the lens may change depending on the stage of development and location in the lens.

Both alpha -crystallins undergo post-translational modifications including truncation of both N and C termini, deamidation, racemization, phosphorylation, methionine oxidation, glycation, disulfide formation, addition of O-GlcNAc, and the addition of 72 mass units to the C-terminal lysine of alpha B-crystallin (4, 17-19, 24, 25). Some of these such as phosphorylation and specific cleavage may be important functionally, others are likely the result of aging and detrimental stresses. Any of these modifications are likely to alter the protein conformation which in turn could alter the aggregate size and/or the function of alpha - crystallin in the cell.

Two-dimensional electrophoresis of tissue proteins is the major technique used to detect post-translationally modified proteins in cell and tissue extracts. We have used this technique extensively in an attempt to identify changes in the concentration or modification of lens proteins that could be unique to developmental, aging, and cataractogenic processes.

In this study we report the identification and characterization of two unique polypeptides observed on two-dimensional gel electrophoresis of human cataracts. One of the proteins was present in high concentration comparable to the concentration of a crystallin. Both are likely the result of stress-induced processes on the path to cataract formation.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Normal Lenses and Cataracts-- Normal human lenses were obtained from the National Disease Research Interchange, Philadelphia, PA. Human cataractous material was obtained from intracapsular cataract surgery done in India and from extracapsular extractions done at the National Eye Institute. Tenets of the Declaration of Helsinki for dealing with human samples were strictly followed. The lens capsule epithelia were removed, and the lenses were separated into the lens cortical and nuclear regions as described previously (26).

Two-dimensional Gel Electrophoresis-- A proteinase inhibitor mixture containing 4-(2-aminoethyl)-benzenesulfonyl fluoride, pepstatin A, trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64), bestatin, leupeptin, and aprotinin (Sigma) was added to frozen lens cortex samples. The samples were thawed and homogenized in 9 M urea, 2 or 4% Nonidet P-40, 10 mM DTT,1 2% Resolyte 3.5-10. Two-dimensional gel electrophoresis was done according to previously described procedures (27, 28). Non-linear, pH 3-10, 18-cm dry strips (Amersham Pharmacia Biotech) were used. Samples were loaded onto the acidic end and focused for 32,000 V-h. The strips were then frozen at least 1 h and equilibrated twice, first in 50 mM Tris, pH 6.8, containing 6 M urea, 1% SDS, with 1% DTT and then in the same buffer mix but with 4.5% iodoacetamide. The second dimension was done in the Iso-Dalt Gel Electrophoresis System using 15-18% gradient gels. Molecular weight markers (Bio-Rad) and pI markers (carbamylated CPK, BDH Laboratory Supplies) were included. Proteins were stained with colloidal Coomassie Blue G-250 or with PhastGel BlueR (Amersham Pharmacia Biotech) when protein spots were analyzed by mass spectrometry. Gels were scanned using a Molecular Dynamics Personal Densitometer, and protein spots were quantified using ImageQuant software.

Protein Sequencing and Immunoreactivity-- Proteins were electrophoretically transferred from the two-dimensional gels to polyvinylidene difluoride membranes (Millipore). Tryptic peptide maps and Edman sequencing were done by Harvard MicroChem. Immunoreactivity was determined using Tropix Western-Light detection kit (PE Applied BioSystems).

Mass Spectrometry-- Proteins were subjected to in-gel digestion with either trypsin (Promega) or Asp-N endoproteinase (Wako) as described previously (29). Extracted peptides were spotted with alpha -cyano-4-hydroxycinnamic acid and analyzed using a PE Biosystems Voyager DE STR matrix-assisted laser desorption-time of flight (MALDI-TOF) mass spectrometer. Data were processed using GRAMS/386 software.

Cloning of alpha B-crystallin and alpha Bg-- RNA was obtained from a 16-year-old human lens. The isolation was done by combining the guanidine isothiocyanate lysis with the silica gel membrane technology using the Qiagen RNeasy kit. Oligo(dT)-primed cDNA was prepared from total RNA using the Amersham Pharmacia Biotech T-primed first strand kit. The coding regions of human alpha B-crystallin and alpha Bg were amplified by PCR using primers containing NcoI or HindIII sites and were inserted into the cloning vector pCR2.1-TOPO (Invitrogen, San Diego, CA). In the PCR reactions the following primer (forward), which corresponds to the 5' end of the coding region of human alpha B-crystallin, was used for both alpha B-crystallin and alpha Bg: 5'-TAAGAAGGAGATATACCATGGACATCGCCA-3'. The reverse primers used for human alpha B-crystallin and alpha Bg were 5'-CAAAAGCTTATTACTATTTCTTGGGGGCTG-3' and 5'-GGCCGCAAGCTTTCACTTGGGGGCTG-3', respectively. The latter will terminate the coding sequence after Lys174. The underlined nucleotides indicate the restriction sites. The clones were propagated in Escherichia coli DH5 alpha TM (Life Technologies Inc.). The coding region of these constructs were confirmed by DNA sequence analysis using the dye terminator cycle sequencing method (PE Applied Biosystems, Warrington, UK).

Construction of Expression Vectors-- The coding region of human alpha B-crystallin and alpha Bg were removed from the cloning vector by double digestion with NcoI and HindIII restriction enzymes and ligated into NcoI-HindIII-cut pET-21d(+) (Novagen, Madison, WI). Recombinant plasmids were identified by NcoI-HindIII digestion and amplification of human alpha B-crystallin by PCR using internal primers.

Expression and Purification of Human alpha B-crystallin and alpha Bg-- Recombinant pET-21d(+)-Halpha BC and pET-21d(+)-Halpha BgC expression plasmids were used to transform competent E. coli BL21(DE3) cells (Stratagene, San Diego, CA). Transformants were grown at 37 °C in 1 liter of Super Broth to A600 = 0.8. alpha B-crystallin and alpha Bg expression were then induced by addition of isopropyl-beta -D-galactospyranoside to a final concentration of 1 mM and then the culture was incubated at 37 °C for 5 h. Cells were collected by centrifugation at 3,000 × g for 10 min at 4 °C and resuspended in 25 ml of lysis buffer, 50 mM sodium phosphate buffer, pH 7, containing 150 mM NaCl, 0.02% sodium azide, and a protease inhibitor mix (Roche Molecular Biochemicals). Cells were disrupted by sonication on ice. The bacterial lysates were then centrifuged at 10,000 × g for 30 min at 4 °C. The alpha B-crystallin and alpha Bg, which were primarily soluble, were purified by gel filtration and ion exchange chromatography. The sequences of alpha B-crystallin and alpha Bg were confirmed by sequencing the plasmids used for the expression and by mass spectral fingerprinting of the expressed proteins. The sequences of the recombinant proteins were identical to those of the proteins in the cataractous lenses with the exception that the recombinant proteins were not acetylated on the N termini.

Isolation of Genomic DNA, alpha B-crystallin Exon 3 Amplification, and Sequencing-- Genomic DNAs were isolated from small pieces of lens tissue (5-10 mg) by a rapid desalting process using a DNA purification kit (Epicentre Technologies) and following the recommendations of the manufacturer. These DNAs (200 ng) served as templates for PCR amplification of exon 3 and flanking regions of human alpha B-crystallin gene (nucleotide identifier (NID) g181075). Primers were 24-mers in length and localized at positions 3722 (upper) and 4172 (lower). PCR cycling conditions were 40 cycles of 94 °C for 5 s, 50 °C for 30 s, and 72 °C for 1 min, using Pfu polymerase (Promega). PCR products were sequenced by the BigDye Terminator method (PE Applied Biosystems) using the same primers.

Chaperone-like Activity-- Chaperone-like activity was measured as the ability to protect against the DTT-induced aggregation of lactalbumin (30). The reaction was done at 23 °C in 50 mM sodium phosphate buffer, pH 6.9, containing 0.1 M NaCl and 2 mM EDTA. Lactalbumin was at 1 mg/ml, and crystallin was at 0.2, 0.5, and 1 mg/ml. Turbidity was measured at 360 nm.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Two unique protein spots were striking on two-dimensional electrophoresis gels of the cortical fiber cell protein from some human cataractous lenses (Fig. 1A). The positions of these proteins are indicated in Fig. 1A. The spot indicated by the thick black arrow migrated at a position one charge more acidic than alpha B-crystallin and at a Mr of 22,400 which is approximately 600 less than alpha B-crystallin (Fig. 1A). The second spot, indicated by the white arrow migrated at a Mr of 16,400. Both of these proteins reacted with antibodies made against recombinant human alpha B-crystallin (Fig. 1B) suggesting that the proteins were related to alpha B-crystallin. Data that will subsequently be presented in this report show that the Mr 22,400 protein is a modified form of alpha B-crystallin. To simplify discussion, this protein will henceforth be referred to as alpha Bg. Neither alpha Bg nor the 16.4-kDa protein has been observed on two-dimensional gels of total fiber cell protein from any normal lens examined (Fig. 2 (a---c)) or in all cataracts. The cataracts shown in Fig. 2 (d---f) that contain alpha Bg were not clinically classified before extraction but were determined to be mixed cataracts by visual examination after intracapsular extraction. The concentration of alpha Bg varied from 10 to 90% of the total alpha B-crystallin (alpha Bg plus alpha B-crystallin) in those cataracts in which it was present. In addition, the total content of alpha B-crystallin (alpha Bg plus alpha B-crystallin) was significantly increased in most of these cataracts. Representative data on three cataracts that contain high concentrations of alpha Bg are shown in Table I. Up to 5 times the normal amount of alpha B-crystallin was seen. This was determined by calculating the ratio of alpha B-crystallin to alpha A-crystallin. The amount of alpha A-crystallin in these cataracts was present at normal concentrations relative to beta -crystallins. To our knowledge, an increase in the concentration of alpha B-crystallin in lenses has not been previously reported.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Two-dimensional gel electrophoresis of a cataractous human lenses. A portion of the two-dimensional gel protein pattern of cortical fiber cell protein was Coomassie stained (A) and immunostained (B) with antibodies against recombinant human alpha B-crystallin (a gift of Dr. J. Horwitz, UCLA). alpha Bg, thick black arrow; typical form of alpha B, white arrowhead; 16.4-kDa fragment, thick white arrow; phosphorylated alpha Bg, thin black arrow; and, typical form of alpha A-crystallin, black arrowhead.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Composite of the alpha B-crystallin and alpha Bg from two-dimensional electrophoresis gels of cataracts and normal human lenses. Indicated is the position of alpha B-crystallin and alpha Bg. The Coomassie-stained gels were scanned and these spots quantified to determine the ratios of the species of alpha B-crystallins present in these cataracts. Normal lenses: a, 57 years; b, 17 years; and c, newborn. Cataracts with alpha Bg: d, e, and f, each were 60-70 years.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Ratio of alpha B/alpha A-crystallin
Cataracts are from donors between 60 and 70 years of age.

alpha -Crystallins are phosphorylated in vivo; however, in the lens the function of the phosphorylation is not known. As can be seen in Fig. 1A (thin black arrow), alpha Bg was the only form of alpha B-crystallin for which a phosphorylated species was obvious; phosphorylated species of the typical form of alpha B-crystallin were not observed. Three phosphorylation sites have been identified for alpha B-crystallin, Ser19, Ser45, and Ser59. Mass spectral data indicated the presence of a phosphate in the peptide corresponding to residues 2-24 in alpha Bg.

Characterization of alpha Bg-- The HPLC chromatograms of the tryptic digests of alpha Bg and alpha B-crystallin from cataracts of two different individuals are presented in Fig. 3. There were no consistent differences between the chromatograms of alpha Bg and alpha B-crystallin that were common to the respective samples from both individuals. Edman sequencing of several tryptic peptides of alpha Bg was performed. For each peptide sequenced there was 100% agreement with the sequence of human alpha B-crystallin (data not shown). These results confirm that the protein is an alpha B-crystallin, albeit, based on the electrophoretic migration, a modified form of alpha B-crystallin. Direct Edman sequencing of alpha Bg, electroblotted onto polyvinylidene difluoride, gave no sequence, suggesting that the N terminus of the protein was blocked. In all alpha Bg samples, a peptide eluting at 40 min corresponded to the C-terminal residues 164-174. Edman sequencing verified the identity of the peptide and the mass of the peptide agreed with its theoretical mass. The presence of C-terminal Lys175 in alpha Bg, however, could not be verified by this experiment because trypsin would cleave between Lys174 and Lys175.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   HPLC chromatograms of tryptic digests of alpha B-crystallin and alpha Bg from two cataracts. Reverse phase HPLC of native alpha B-crystallin and alpha Bg. Tryptic peptides were monitored at A205.

Mass fingerprinting was done on trypsin and Asp-N protein digests of alpha B-crystallin and alpha Bg using MALDI-TOF mass spectrometry. The results are illustrated in Tables II and III. In Table II, the protonated molecular weights for those peptides derived by trypsin digestion of alpha B-crystallin and alpha Bg, as well as the theoretical protonated molecular weights, are listed. The presence of peptides with m/z values of 1430.7 and 1431.0 in the tryptic digests of alpha Bg from both samples indicate that the N terminus is present and acetylated. In the trypsin digests there were a few masses that could not be assigned, but there were no masses consistently present in alpha Bg that were missing in alpha B-crystallin or vice versa.

                              
View this table:
[in this window]
[in a new window]
 
Table II
alpha B-Crystallin tryptic digest products determined by MALDI-TOF mass spectrometry

In Table III, the masses for the peptides derived by Asp-N endoproteinase digestion are listed. alpha B-crystallin samples contained peptides with m/z 3842.9 and 3842.0. These molecular weights are consistent with the C-terminal peptide, residues 140-175, that has a theoretical m/z value of 3842.4. A mass that corresponded to this peptide was absent in both alpha Bg samples, but in both cataracts alpha Bg contained a peptide absent in either alpha B-crystallin spot, with m/z values of 3715.0 and 3714.4 (Fig. 4). These masses are consistent with the theoretical m/z value of the C-terminal peptide minus Lys175, 3714.3. Asp-N endoproteinase does not remove Lys175; therefore, the digest product of residues 140-174 from alpha Bg confirms that Lys175 is not present on alpha Bg. In the Asp-N digests there were very few masses that could not be assigned, and other than the differences just discussed there were no other peptide masses that were present in alpha Bg that were missing in alpha B or vice versa. Only one peak corresponding to residues 129-139 (DPLTITSSLSS) was consistently absent in Asp-N spectra, and it was not present in either crystallin. In cataract B, there was evidence for Met68 being present as methionine sulfoxide in both alpha B-crystallin and alpha Bg. The m/z value of 1294.9 is consistent with the expected molecular weight of residues 62-72 plus a mass of 16 mass units. The theoretical m/z value of the same peptide with Met68 oxidized is 1294.61. Between the two enzymatic digestions spectra were obtained for peptides that covered 100% of the polypeptide sequence. The regions of the polypeptide that could not be accounted for by tryptic peptides were accounted for with the peptides from Asp-N digests and the reverse was also true, making it possible to detect a difference in any residue of alpha B-crystallin and alpha Bg. There were no unique modifications, amino acid substitutions, or internal deletions detected in alpha Bg. The excellent agreement of the masses obtained on the peptide digests of alpha Bg with the respective theoretical masses of the same peptides in alpha B-crystallin indicate that there is only one difference between alpha Bg and alpha B-crystallin. The terminal Lys175 is missing in alpha Bg.

                              
View this table:
[in this window]
[in a new window]
 
Table III
alpha B-crystallin Asp-N endoproteinase digest products determined by MALDI-TOF mass spectrometry


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Mass spectra of C-terminal, Asp-N endoproteinase digest peptides of native alpha B-crystallin and alpha Bg. Protein spots of alpha B-crystallin and alpha Bg were cut out of a two-dimensional gel and subjected to in-gel digestion by Asp-N endoproteinase. Resultant peptides were extracted and analyzed by MALDI-TOF mass spectrometry. The portions of the spectra showing the difference between alpha B-crystallin and alpha Bg are shown. The m/z value of 3842.9 corresponds to the singly charged peptide of residues 140-175, which has a theoretical average m/z of 3842.4. The m/z 3714.4 corresponds to the singly charged peptide of residues 140-174, which has a theoretical average m/z of 3714.3. The absence of a peak at m/z 3842.4 and the coincident mass at m/z 3714.4 in the spectrum of alpha Bg indicates that Lys175 is not present in alpha Bg.

The loss of the C-terminal lysine could readily explain the migration of alpha Bg on two-dimensional gel electrophoresis at a position 1 charge more acidic than the typical form of alpha B-crystallin. However, it did not seem likely that the loss of one lysine (128 mass units) could explain the migration of alpha Bg at the lower molecular weight. The only reasonable explanations were that alpha Bg had region(s) of structure different from alpha B-crystallin that remained throughout the electrophoresis even in the presence of 9 M urea, 2% Nonidet P-40 or 1% SDS and affected its electrophoretic migration, or that an adduct was lost during the subsequent analyses.

Recombinant Human alpha B-crystallin and alpha Bg-- To test whether the removal of the C-terminal lysine was sufficient to induce the altered migration on electrophoresis as was observed in the second dimension of two-dimensional electrophoresis, both human alpha B-crystallin and human alpha B-crystallin minus the C-terminal lysine (alpha Bg) were cloned and expressed in E. coli. Both were expressed as soluble proteins in this system. Neither protein was acetylated on the N-terminal methionine. The recombinant human alpha B-crystallin and the recombinant human alpha Bg eluted from a Superose 6 gel filtration column as aggregates with apparent molecular weights of 570,000 and 510,000, respectively (Fig. 5). Significantly smaller species were also observed for alpha Bg (data not shown). As shown in Fig. 6A, even after boiling in SDS, the recombinant alpha Bg migrated slightly faster than recombinant alpha B-crystallin on SDS-PAGE. The calculated difference in the molecular weight between the recombinant alpha B-crystallin and recombinant alpha Bg was approximately 700, similar to the difference observed on two-dimensional gels of lens proteins. These results show that the removal of the C-terminal lysine is sufficient to cause the migration of alpha Bg at a significantly lower molecular weight than alpha B-crystallin. The pI values determined by isoelectric focusing under non-denaturing conditions for both proteins are shown in Fig. 6B. The recombinant alpha B-crystallin had a native pI of 6.8, and recombinant alpha Bg had a native pI of 5.8. The theoretical pI values are 6.76 and 6.50, respectively.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Oligomeric sizes of recombinant human alpha B crystallin and alpha Bg. Recombinant human alpha B-crystallin and alpha Bg were purified by gel filtration and ion exchange chromatography. The figure is an overlay of the final purification chromatograms of both recombinant proteins from a Superose 6 HR 10/30 gel filtration column. Recombinant human alpha B-crystallin peak (solid line) eluted at ~570 kDa (90% of the peak area was in the range of 270-970 kDa) and recombinant human alpha Bg peak (dotted line) eluted at ~510 kDa (90% of the peak area was in the range of 260-940 kDa). The column was calibrated immediately before purification of both recombinants using thyroglobulin (669 kDa), beta -amylase (200 kDa), bovine serum albumin (66 kDa), and carbonic anhydrase (30 kDa) (inset).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 6.   SDS-PAGE and native isoelectric focusing of recombinant human alpha B-crystallin and alpha Bg. The relative sizes of the subunits of purified rhalpha B-crystallin and rhalpha Bg were calculated from their migration on 14% polyacrylamide gels. The relative isoelectric points of the two recombinants were calculated from their migration under native conditions on 5% polyacrylamide isoelectric focusing gel. SDS-PAGE: lanes 1 and 6, molecular weight markers; lanes 2 and 3, rhalpha B-crystallin (21.5 kDa); lanes 4 and 5, rhalpha Bg (20.7 kDa). Native isoelectric focusing: lanes 1 and 6, isoelectric point markers; lanes 2 and 3, rhalpha B-crystallin (pI 6.8); lanes 4 and 5, rhalpha Bg (pI 5.8).

Chaperone-like Activity-- alpha -Crystallins exhibit a chaperone-like activity, protecting against aggregation of proteins that is induced by heat, oxidation, and reduction by DTT (30). The effect of the removal of the C-terminal lysine on the chaperone-like activity of alpha B-crystallin was assessed by determining the ability of the recombinant forms of human alpha B-crystallin and alpha Bg to prevent the DTT-induced aggregation of lactalbumin. As shown in Fig. 7, the removal of the C-terminal lysine had essentially no effect on the chaperone-like activity of this protein under these conditions.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Chaperone-like activity of recombinant human alpha B-crystallin and alpha Bg. The incubation mixture contained 50 mM sodium phosphate, 0.1 M NaCl, 2 mM EDTA, pH 6.9, 50 mM DTT, and 1 mg/ml alpha -lactalbumin, in the absence () and presence of rhalpha B-crystallin, 1 mg/ml (black-square), 0.5 mg/ml (black-triangle), and 0.2 mg/ml (+) (A); 1 mg/ml alpha -lactalbumin in the absence () and presence of rhalpha Bg 1 mg/ml (), 0.5 mg/ml (triangle ), and 0.2 mg/ml (×) (B).

16.4-kDa Protein-- The 16.4-kDa protein was present at a concentration about one-tenth that of alpha Bg and has only been observed in samples that contain alpha Bg. Direct Edman sequencing was performed on the 16.4-kDa protein from cataracts of two different individuals. These data are shown in Fig. 8. The 16.4-kDa protein in lens 1 yielded multiple N-terminal sequences, Ser43, Ser41, Ser45, and Phe47. All sequences were identical to alpha B-crystallin. MALDI-TOF derived data on the 16.4-kDa protein from a third individual indicated the N termini were Ser43 and Ser41. In a fourth individual the N terminus was Pro39 (Table IV). Two of the cleavages were between Thr and Ser, one between Leu and Ser, one between Pro and Phe, and the fourth was between Phe and Pro. The significance of these data is that multiple N termini have been identified, each different by two or multiples of two residues.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 8.   N-terminal sequences of alpha B-crystallin 16-kDa fragments. N-terminal sequences of the 16.4 kDa are compared with the alpha B-crystallin sequence. Sequencing was performed by Harvard MicroChem. Underlined residues are lower confidence. For lens 1, determination of the predominance of sequences was done by Harvard Microchem using the relative concentrations of amino acids in each cycle and the typical yields of each amino acid.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
16.4-kDa protein Asp-N digest products determined by MALDI-TOF mass spectrometry

Tryptic digests of this spot were similar but not identical to that of alpha B-crystallin. A peptide with a mass of 1140 Da that eluted at the same time as a peptide identified by sequencing as residues 164-174 was present. MALDI-TOF mass spectral analysis of Asp-N endoproteinase digests showed the absence of a peak at m/z 3842.4 which would correspond to residues 140-175 of alpha B-crystallin (Table IV). There was, however, a peak at m/z 3714.5 which corresponds to residues 140-174. As shown in Table IV, experimental m/z values were matched to theoretical m/z values from Asp-N cleavage that covered most of the polypeptide. Aside from the N-terminal peptides, the only mass missing was the same one not observed in alpha B and alpha Bg. A unique peak at m/z 3130.5 was observed. This mass may correspond to residues 39-66 (3129.8). These results show that the 16.4-kDa protein is derived from alpha Bg.

Genomic Analysis-- The mechanism by which alpha Bg is generated in these cataractous lenses is not known. One possibility was that alpha Bg is the product of a mutated gene for alpha B-crystallin since a single nucleotide change could convert the codon for lysine to a stop codon. To test this possibility PCR products were obtained for the last exon of the alpha B-crystallin gene using genomic DNA prepared from lenses containing alpha Bg. The sequences of the PCR products indicated that there was no mutation in the gene for alpha B-crystallin (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have demonstrated that in some human cataracts the concentration of the small heat shock protein, alpha B-crystallin, is significantly increased. This could be the result of an up-regulation of its expression and/or a diminution of its degradation in the lens. Regardless, it represents a significant deviation from the normal protein composition of the lens and is the first time such an observation has been made in a human cataract. We have also provided evidence for aberrant N- and C-terminal processing of alpha B-crystallin. One atypical form of alpha B-crystallin found in high concentrations in these cataracts has been designated alpha Bg. This species is alpha B-crystallin minus the C-terminal lysine. A second atypical form of alpha B-crystallin, found at about 10% the concentration of alpha Bg, is a 16.4-kDa fragment of alpha Bg. In this protein 38-46 N-terminal residues have also been removed.

The removal of the C-terminal lysine does not diminish the chaperone-like activity of alpha B-crystallin under the conditions used for these studies. As reported here (Fig. 7) the chaperone-like activity of the recombinant human alpha Bg is comparable to that of the recombinant human alpha B-crystallin in protecting against the DTT-induced aggregation of lactalbumin at room temperature. alpha A- and alpha B-crystallin have polar, flexible C-terminal extensions that are thought to contribute to the solubility of these crystallins and have been implicated in their chaperone-like activity (31). Substitution of Lys174-Lys175 of alpha B-crystallin with Leu-Leu significantly diminished chaperone-like activity; however, removal of the last 5 residues had little effect on chaperone-like activity (32). Likewise, in alpha A-crystallin the introduction of tryptophan at the C terminus and removal of 17 C-terminal residues diminished chaperone activity (33-35). Maintenance of a polar, flexible C-terminal extension appears to be an important factor for maintaining chaperone-like activity (33). Thus, it is not surprising that alpha Bg has full activity in protecting against the DTT-induced aggregation of lactalbumin.

The only modification identified for alpha Bg was the loss of Lys175. There was nothing in the mass spectral, HPLC, and protein sequence data that suggested an additional modification. The N and C termini of the protein were otherwise intact. The N-terminal methionine was acetylated, and every peptide sequence examined matched alpha B-crystallin exactly. With the exception of the mass corresponding to the loss of the C-terminal lysine, there were no masses found by MALDI-TOF mass spectrometry that were consistently present in alpha Bg that were not present in alpha B-crystallin from the same cataract and vice versa. This held for both Asp-N and trypsin digests of the proteins, and, combining data from both digests, the entire sequences of both alpha Bg and alpha B-crystallin were analyzed. These data rule out splice variants and other mutations unless replacements have the same mass and would not be detected in the MALDI-TOF mass spectrometry fingerprint analysis.

It was confirmed that the removal of the carboxyl-terminal lysine (128.09 mass units) was responsible for the faster migration of alpha Bg on SDS-PAGE relative to alpha B-crystallin. This was demonstrated using the recombinant forms of these proteins. In addition to showing that a difference of one lysine was sufficient to alter the migration on SDS-PAGE, it also supported the conclusion that the only modification of alpha Bg was the lack of the terminal lysine. Smulders et al. (33) demonstrated that a mutant of alpha A-crystallin with an extension of ALRKG migrated on SDS-PAGE slightly slower than mutants with ALGKG or ALDKG. Thus, addition of one more positive charge in the C-terminal extension of either alpha A- or alpha B-crystallin can slightly retard its electrophoretic mobility.

In this study, alpha Bg and the 16.4-kDa proteins were only observed in cataracts but not in all human cataracts. Over 70 cataracts from 60 to 90 years have been analyzed. Eight cataracts have the high concentration of alpha Bg. Many other cataracts have alpha Bg but at lower concentrations. So far, a correlation cannot be made between the presence of these proteins in cataracts and any cataract etiology. Neither alpha Bg nor the 16.4-kDa fragment have been observed in our laboratory on two-dimensional electrophoresis of normal human lens total protein, water-soluble or water-insoluble fractions, of about 50 non-cataractous lenses (newborn to 75 years). However, the presence in a normal lenses of a low concentration of an alpha -crystallin with a mass that corresponded to alpha B-crystallin minus the C-terminal lysine has been reported using liquid chromatography/mass spectrometry (36-38). The sensitivity of electrospray ionization mass spectrometry made the detection of very low levels of alpha Bg in non-cataractous lenses possible, whereas Fig. 2 clearly shows that alpha Bg is not detected by Coomassie Blue staining of normal lens proteins. The findings in other laboratories suggest that at least very low concentrations of alpha Bg may exist in normal lenses and that alpha Bg and possibly the 16.4-kDa fragment may be intermediates in the normal pathway of processing alpha B-crystallin (36-38). In the cataracts examined in this study, there may be increases and/or decreases in proteinases that result in the accumulation of these species. Interestingly, alpha A-crystallin which has Ser-Ser as the final C-terminal residues is found with only the final Ser removed (60). This form of alpha A-crystallin has been observed in normal human and bovine lenses. The functional significance of the modified form is not known. Furthermore, the significance of the processing of alpha -crystallins to cataractogenesis is not known.

Multiple proteinases are certain to be involved in the post-translational modification of alpha B-crystallin generating alpha Bg and the 16.4-kDa fragment. The data reported in this study rule out the possibility that alpha Bg is the result of a mutation in the alpha B-crystallin gene but cannot rule out a genetic component involving other genes such as proteinases or involving the regulation of proteinases. There was a high incidence of alpha Bg in cataracts from India. This supports the possibility of a genetic component. Alternatively, the high incidence in cataracts from India could indicate the presence of a particular form of stress on the lens which alters the proteinase activities.

In alpha Bg the terminal lysine is removed but not the penultimate lysine. The first cleavage would be a Lys-Lys cleavage and the second a Pro-Lys cleavage. Carboxypeptidases have been described that are specific for basic amino acids for which the penultimate amino acid alters the rate of cleavage (39). Peptide carboxypeptidases have been described that will not cleave prolysyl bonds, and endopeptidases with specificity for pairs of basic amino acids that will remove one or both of the basic residues have been described (39). Thus, the specificity for removing one but not both lysine residues is possible; however, whether any of these proteinases are in the lens is not known. If the removal of the C-terminal lysine is related to function, it is possible a specific carboxypeptidase may be induced during stress.

The 16.4-kDa protein is an N-terminally truncated form of alpha Bg and was only observed in those lenses in which alpha Bg was in high concentration. Multiple N termini were identified, but the major N terminus was Ser43. Since each N terminus represented the removal of two residues or multiples of two, it is reasonable to suggest that cleavage is catalyzed by a dipeptidyl peptidase. Dipeptidyl peptidases II (lysosomal) and III (cytoplasmic) are present in lens and cataracts (40, 41). However, both of these preferentially use peptides as substrates, not proteins. Dipeptidyl peptidases that utilize proteins as substrates exist but, to our knowledge, have not been described in the lens. The N termini of alpha Bg and alpha B-crystallin are blocked, so presumably a different proteinase made the first cleavage. Acylaminohydrolases that could cleave the acetylmethionine are present in lenses (42).

Our hypothesis is that a stress mechanism is involved in generating both the high concentrations of alpha B-crystallin and the subsequently modified forms, alpha Bg and the 16.4-kDa protein, and that the increased concentration of alpha B-crystallin is an effort by the lens to protect against loss of lens function. That a stress mechanism is involved is strongly supported by our observation that alpha Bg was present in the lens from an infant with microphthalmia, coloboma, and persistent hyperplastic primary vitreous.2 The latter is a condition where the vessels do not regress at the appropriate time in development and cells invade the back of the lens. Our assumption is that this is perceived by the lens as an extreme stress condition. In addition, two forms of alpha B-crystallin were induced in hypertonically stressed dog lens epithelial cells in culture (21). Direct evidence is not yet available, but it is highly likely, based on the migration on two-dimensional gels, that the atypical form of alpha B-crystallin found is alpha Bg. alpha B-crystallin is a member of the family of small heat shock proteins and in cultured cells, including lens cells, alpha B-crystallin is induced by heat shock, oxidative stress, osmotic stress, sodium arsenite, phorbol 12-myristate 13-acetate, and hormones such as estrogen and dexamethasone (20-23, 43, 44). Heat shock proteins are also phosphorylated in response to stress (45). alpha -Crystallins are phosphorylated in vivo and in vitro (46-48). The role of phosphorylation of alpha B-crystallin in lens is not understood, but alpha Bg was preferentially phosphorylated in the cataracts examined.

This is the first time an increased concentration of alpha B-crystallin has been described in vivo in human lenses. The increased concentration is due to the presence of alpha Bg not to an increased concentration of the typical form of alpha B-crystallin. Due to the nature of the lenses, it is difficult to determine whether there is truly an increased expression or a decreased degradation of alpha B-crystallin. If the increased concentration of alpha B-crystallin reflects diminished processing, the degradation of this protein must occur at a much greater rate in human lens than previously appreciated. We propose that there is an increased expression due to chronic stress conditions and altered processing of alpha B-crystallin generating alpha Bg in these cataracts. alpha B-crystallin also accumulates in brains of individuals with neurological disorders (49-51). It is unclear in these cases, as well as the cataracts, whether the presence of alpha B-crystallin is an attempt to rescue the tissue or if it is a contributor to the pathology. We think it is unlikely that the increased concentration of alpha B-crystallin and the presence of the modified forms cause the loss of lens clarity in the cataracts, but it must be considered.

The functional significance of the post-translational modification of alpha B-crystallin described here is not known. In the intact lens, it is unclear whether the primary function of alpha B-crystallin is that of a stress protein and related to its chaperone-like activity or if it is structural. The findings that alpha Bg is present in a lens with persistent hyperplastic primary vitreous and is induced by hypertonic stress in lens cells suggests a major role is stress-related. Based on a number of reports, alpha B-crystallin interacts with actin, intermediate filaments, membranes, and components in cell nuclei (52-57). Lys175 has been implicated as an amine donor substrate for transglutaminase reactions (58, 59). The data presented suggest alpha Bg has some difference in structure from the typical form of alpha B-crystallin. This is likely to alter specific protein-protein interactions. In fact, the larger than expected change in the native pI of alpha Bg supports the observations that the C-terminal lysine is involved in intramolecular interactions and is likely to affect intermolecular interactions as well. Further evidence for this is the preferential phosphorylation of alpha Bg over alpha B-crystallin.

Studies in progress will hopefully elucidate the mechanisms involved in the increased concentration of alpha B-crystallin and the function of alpha Bg in lens and in cataracts. They will also determine whether the pathway for modification of alpha B-crystallin is one specific to lens or is a general pathway induced by stress in other tissues.

    ACKNOWLEDGEMENTS

We are very grateful to the tissue and organ donors and their families for their contribution to this study.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Both authors contributed equally to this work.

Dagger Dagger Present address: Ophthalmology Dept., University of Modena, Modena, Italy.

§§ To whom correspondence should be addressed: Laboratory of Mechanisms of Ocular Diseases, NEI, Bldg. 6, Rm. 235, National Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-6999; Fax: 301-496-1759; E-mail: dgarland@helix.nih.gov.

2 D. Garland, unpublished data.

    ABBREVIATIONS

The abbreviations used are: DTT, dithiothreitol; PCR, polymerase chain reaction; MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; PAGE, polyacrylamide gel electrophoresis; HPLC, high pressure liquid chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Hoenders, H. J., and Bloemendal, H. (1983) J. Gerontol. 38, 278-286[Medline] [Order article via Infotrieve]
2. Bloemendal, H. (ed) (1981) Molecular and Cellular Biology of the Eye Lens , pp. 279-405, John Wiley & Sons, Inc., New York
3. Harding, J. J., and Dilley, K. J. (1976) Exp. Eye Res. 22, 1-73[CrossRef][Medline] [Order article via Infotrieve]
4. Groenen, P. J., Merck, K. B., de Jong, W. W., and Bloemendal, H. (1994) Eur. J. Biochem. 225, 1-19[Medline] [Order article via Infotrieve]
5. Dubin, R. A., Wawrousek, E. F., and Piatigorsky, J. (1989) Mol. Cell. Biol. 9, 1083-1091[Abstract/Free Full Text]
6. Bhat, S. P., and Nagineni, C. N. (1989) Biochem. Biophys. Res. Commun. 158, 319-325[CrossRef][Medline] [Order article via Infotrieve]
7. Srinivasan, A. N., Nagineni, C. N., and Bhat, S. P. (1992) J. Biol. Chem. 267, 23337-23341[Abstract/Free Full Text]
8. Bindels, J. G., Bessems, G. J., de Man, B. M., and Hoenders, H. J. (1983) Comp. Biochem. Physiol. B 76, 47-55[CrossRef][Medline] [Order article via Infotrieve]
9. Augusteyn, R. C. (1998) Exp. Eye Res. 66, 669-674[CrossRef][Medline] [Order article via Infotrieve]
10. Ingolia, T. D., and Craig, E. A. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2360-2364[Abstract/Free Full Text]
11. Klemenz, R., Andres, A. C., Frohli, E., Schafer, R., and Aoyama, A. (1993) J. Cell Biol. 120, 639-645[Abstract/Free Full Text]
12. de Jong, W. W., Hendriks, W., Mulders, J. W., and Bloemendal, H. (1989) Trends Biochem. Sci. 14, 365-368[CrossRef][Medline] [Order article via Infotrieve]
13. Wistow, G. (1985) FEBS Lett. 181, 1-6[CrossRef][Medline] [Order article via Infotrieve]
14. Merck, K. B., Groenen, P. J., Voorter, C. E., de Haard-Hoekman, W. A., Horwitz, J., Bloemendal, H., and de Jong, W. W. (1993) J. Biol. Chem. 268, 1046-1052[Abstract/Free Full Text]
15. Horwitz, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10449-10453[Abstract/Free Full Text]
16. Jakob, U., Gaestel, M., Engel, K., and Buchner, J. (1993) J. Biol. Chem. 268, 1517-1520[Abstract/Free Full Text]
17. de Jong, W. W., Mulders, J. W., Voorter, C. E., Berbers, G. A., Hoekman, W. A., and Bloemendal, H. (1988) Adv. Exp. Med. Biol. 231, 95-108[Medline] [Order article via Infotrieve]
18. Smith, J. B., Sun, Y., Smith, D. L., and Green, B. (1992) Protein Sci. 1, 601-608[Abstract]
19. Chiesa, R., Gawinowicz-Kolks, M. A., Kleiman, N. J., and Spector, A. (1987) Biochem. Biophys. Res. Commun. 144, 1340-1347